Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy.

Veselska, Renata; Jezova, Marta; Kyr, Michal; Mazanek, Pavel; Chlapek, Petr; Dobrotkova, Viera; Sterba, Jaroslav

Veselska, Renata; Jezova, Marta; Kyr, Michal; Mazanek, Pavel; Chlapek, Petr; Dobrotkova, Viera; Sterba, Jaroslav.

Afiliación

Veselska R; Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
Jezova M; Department of Pediatric Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czechia.
Kyr M; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia.
Mazanek P; Department of Pathology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czechia.
Chlapek P; Department of Pediatric Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czechia.
Dobrotkova V; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia.
Sterba J; Department of Pediatric Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czechia.

Front Oncol ; 9: 1221, 2019.

Article en En | MEDLINE | ID: mdl-31803613

Palabras clave

HOXC9; NF1; PBX1; immunohistochemistry; neuroblastoma; predictive markers; prognostic markers

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google